^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Adstiladrin (nadofaragene firadenovec-vncg)

i
Company:
FKD Therapies, Ferring, Royalty
Drug class:
IFNα stimulant
Phase 3
Ferring Ventures Limited
Active, not recruiting
Last update posted :
11/08/2024
Initiation :
01/21/2019
Primary completion :
03/29/2024
Completion :
04/01/2026
MSLN • EFEMP1
|
gemcitabine • Adstiladrin (nadofaragene firadenovec-vncg) • celecoxib oral
Phase 2
FKD Therapies Oy
Completed
Last update posted :
07/24/2017
Initiation :
09/01/2012
Primary completion :
10/01/2015
Completion :
01/01/2016
IFNA1
|
IFNA2 elevation
|
Adstiladrin (nadofaragene firadenovec-vncg)
Phase 1
Merck Sharp & Dohme LLC
Completed
Last update posted :
03/27/2015
Initiation :
09/01/2006
Primary completion :
08/01/2009
Completion :
08/01/2009
IFNA1
|
Adstiladrin (nadofaragene firadenovec-vncg)